The variant heterozygous genotype of the TLR9 rs5743836 SNP conferred almost a fourfold increased risk of B-cell Non-Hodgkin lymphomas (B-NHL) in patients from Egypt (OR = 3.93, 95% CI = 2.16–7.14) [22]. This evidence concerns the gene TLR9 and B-cell non-Hodgkin lymphoma.